Anonymous ID: 0335e5 July 8, 2021, 5:44 a.m. No.14079653   🗄️.is 🔗kun   >>9668

>>14079605

At the CIA President Trump spoke of removing columns. Anon does not recall anything about getting rid of arches. Do you have a source?

 

"And maybe - maybe - it’ll be built by somebody that knows how to build and we won’t have columns [laughter] You understand that? We’d get rid of the columns." At Langley 1/21/2017

Anonymous ID: 0335e5 July 8, 2021, 7:52 a.m. No.14080350   🗄️.is 🔗kun

>>14080268

'..why are all the unvaxxed people not dying?'

That's a fair question. Study the Dengue Fever Dengvaxia scandal or read about ADE:

 

https://www.nature.com/articles/s41564-020-00789-5

 

One potential hurdle for antibody-based vaccines and therapeutics is the risk of exacerbating COVID-19 severity via antibody-dependent enhancement (ADE). ADE can increase the severity of multiple viral infections, including other respiratory viruses such as respiratory syncytial virus (RSV) and measles. ADE in respiratory infections is included in a broader category named enhanced respiratory disease (ERD), which also includes non-antibody-based mechanisms such as cytokine cascades and cell-mediated immunopathology (Box 1). ADE caused by enhanced viral replication has been observed for other viruses that infect macrophages, including dengue virus and feline infectious peritonitis virus (FIPV). Furthermore, ADE and ERD has been reported for SARS-CoV and MERS-CoV both in vitro and in vivo. The extent to which ADE contributes to COVID-19 immunopathology is being actively investigated.